Human primary hepatocytes, recovery, plating, and induction media
Ended Purchase Order Awarded Last action
- Contract number
- 75F40123P00249
- Awardee
-
Discovery Life Sciences, LLC UEI GDJDUFGMSC14
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $47,945
Award facts
- Contract value 100% obligated
- $47,945.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Huntsville, AL 35806, USA
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration awarded a purchase order to Discovery Life Sciences, LLC, a small disadvantaged business, for $47,945.00 on July 27, 2023, under a total small business set-aside for human primary hepatocytes, recovery, plating, and induction media. Work is performed in Huntsville, Alabama, with a firm fixed-price structure and an ultimate completion date of September 30, 2023.
Quick answers
Who was awarded contract 75F40123P00249?
75F40123P00249 was awarded to Discovery Life Sciences, LLC by Food and Drug Administration (Department of Health and Human Services) on July 27, 2023.
How much is contract 75F40123P00249 worth?
The government has obligated $47,945 on 75F40123P00249.
Was contract 75F40123P00249 competed?
The extent of competition for 75F40123P00249 was competed under sap. The government received 2 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award